AVR anteris technologies global corp.

Cleveland Clinic has enrolled patients in EFS, page-25

  1. 5,931 Posts.
    lightbulb Created with Sketch. 981
    Hi all --cgt200...................... please tell me I am dreaming - or totally stuffed my understanding of the information/trial (I did a quick read) :- Sorry for the spacing at bottom - could not reduce-----look at last cut-n-paste -- 3rd one down 12-2033 ? 'redant ' 7:53 am Nah I must be wrong? Maybe it is the 'final closing' of the overall trial??

    Study Type:Interventional (Clinical Trial)
    1EstimatedEnrollment:15 participants
    2Allocation:N/A
    3Intervention Model:Single Group Assignment
    4Intervention Model Description:A prospective, non-randomized, single-arm, multi-center study
    5Masking:None (Open Label)
    6Primary Purpose:Device Feasibility
    7Official Title:Use of DurAVR™ THV System in Subjects With SevereAorticStenosis: Early Feasibility Study
    8EstimatedStudy Start Date:July 2023
    9EstimatedPrimary Completion Date:August 2023
    10EstimatedStudy Completion Date:December 2033


    Study Start(Estimated)
    2023-07
    Primary Completion(Estimated)
    2023-08
    Study Completion(Estimated)
    2033-12
    Enrollment(Estimated)
    15
    Study Type
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.20
Change
0.070(1.36%)
Mkt cap ! $80.62M
Open High Low Value Volume
$5.20 $5.30 $5.10 $61.72K 11.90K

Buyers (Bids)

No. Vol. Price($)
1 500 $5.10
 

Sellers (Offers)

Price($) Vol. No.
$5.30 600 1
View Market Depth
Last trade - 15.54pm 01/08/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.